Sammy Saab, Douglas R. Hunt, Michael A. Stone, Amy McClune, Myron J. Tong – 23 March 2010 – Antiviral therapy for the treatment of hepatitis C virus (HCV) infection is used before and after liver transplantation. The objective of this study was to determine the most cost‐effective timing for pegylated interferon/ribavirin therapy in patients with advanced liver disease infected with genotype 1 HCV.

Carina Riediger, Michael W. Müller, Christoph W. Michalski, Norbert Hüser, Tibor Schuster, Jörg Kleeff, Helmut Friess – 23 March 2010 – The routine use of a T‐tube in reconstruction of the biliary tree during orthotopic liver transplantation (OLT) is controversial. A systematic review of the literature on the use of a T‐tube in reconstruction of the biliary tree was performed. Retrospective studies were only reviewed, whereas prospective randomized studies were included in the meta‐analysis. An analysis of 196 studies revealed that 91 studies investigated the use of a T‐tube in OLT.

Allan M. Concejero, Chee‐Chien Yong, Chao‐Long Chen, Hung‐I Lu, Chih‐Chi Wang, Shih‐Ho Wang, Yueh‐Wei Liu, Chin‐Hsiang Yang, Yu‐Fan Cheng, Bruno Jawan – 8 March 2010 – Our objectives were to define the incidence and etiology of solitary pulmonary nodules (SPNs) in patients undergoing living donor liver transplantation (LDLT), describe a diagnostic approach to the management of SPNs in LDLT, and define the impact of SPNs on the overall survival of adult LDLT recipients.

Pinelopi Manousou, AP Dhillon, Andrew K Burroughs – 8 March 2010

Dorry L. Segev, Robert A. Montgomery – 8 March 2010

Benjamin L. Shneider, Mark S. Roberts, Kyle Soltys – 8 March 2010

Karl‐Heinz Schulz, Sylvia Kroencke – 8 March 2010

Maartje A. J. van den Broek, Steven W. M. Olde Damink, Bjorn Winkens, Christoph E. Broelsch, Massimo Malagó, Andreas Paul, Fuat H. Saner – 5 March 2010 – Clinically significant infections (CSIs) are life‐threatening but difficult to diagnose after liver transplantation (LTx). This study investigates the value of procalcitonin (PCT) in addition to c‐reactive protein (CRP) and the leukocyte count (LC) as a prognostic marker for CSIs in LTx recipients. The clinical course of 135 LTx recipients was prospectively studied.

Zhengrong Shi, Lunan Yan, Jichun Zhao, Bo Li, Tianfu Wen, Mingqing Xu, Wentao Wang, Zheyu Chen, Jiaying Yang – 5 March 2010 – Implantable pumps have been used to prevent deep vein thrombosis and other diseases. In this article, we report for the first time the prevention and treatment of rethrombosis of the portal vein in liver transplantation with an implantable pump of the portal vein.

Constantino Fondevila, Amelia J. Hessheimer, Pilar Taurá, Olga Sánchez, David Calatayud, Nicolas de Riva, Javier Muñoz, Jose Fuster, Antoni Rimola, Juan C. García‐Valdecasas – 5 March 2010 – Understanding the pathogenesis of small‐for‐size (SFS) syndrome is critical to expanding the applicability of partial liver transplantation. We aimed to characterize its acute presentation and association with alterations in hepatic hemodynamics, microstructure, and regeneration in a porcine model. Eighteen SFS liver transplants were performed. Donors underwent 70% hepatectomy.